Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 26 , ISSUE 2 ( February, 2022 ) > List of Articles

LETTER TO THE EDITOR

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links

Praneet Vashishtha, Nipun Gupta, Ravi Wadke, Priya Taank

Keywords : COVID-19, Hydroxychloroquine, Intravenous immunoglobulin, Myasthenia gravis

Citation Information : Vashishtha P, Gupta N, Wadke R, Taank P. Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links. Indian J Crit Care Med 2022; 26 (2):248-249.

DOI: 10.5005/jp-journals-10071-23930

License: CC BY-NC 4.0

Published Online: 09-02-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Abstract

HTML PDF Share
  1. Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci 2020;414:116888. DOI: 10.1016/j.jns.2020.116888.
  2. International MG/COVID-19 Working Group, Jacob S, Muppidi S, Guidon A, Guptill J, Hehir M, et al. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci 2020;412:116803. DOI: 10.1016/j.jns.2020.116803.
  3. Guidon AC, Amato AA. COVID-19 and neuromuscular disorders. Neurology 2020;94(22):959–969. DOI: 10.1212/WNL.0000000000009566.
  4. Bonilla FA. Adverse effects of immunoglobulin G therapy: thromboembolism and haemolysis. Clin Exp Immunol 2014;178 (Suppl. 1):72–74. DOI: 10.1111/cei.12518.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.